Welcome to our dedicated page for Electromed news (Ticker: $ELMD), a resource for investors and traders seeking the latest updates and insights on Electromed stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Electromed's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Electromed's position in the market.
Rhea-AI Summary
Electromed, Inc. announced the schedule for its Third Quarter Fiscal 2024 Financial Results Conference Call on May 7, 2024, at 5:00 p.m. ET. Interested parties can dial in or access the webcast to discuss the financial results for the fiscal quarter ended March 31, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.26%
Tags
-
Rhea-AI Summary
Electromed, Inc. (NYSE American: ELMD) announced that its President and CEO, Jim Cunniff, and CFO, Brad Nagel, will attend the 2024 Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference on April 17-18, 2024. The management team will present at 10:30 a.m. Eastern Time on April 18, 2024. Interested individuals can register for the free webcast to view the presentation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.35%
Tags
-
Rhea-AI Summary
Electromed, Inc. (ELMD) executives to attend 2024 Sidoti March Small-Cap Virtual Conference. Webcast available on company website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.8%
Tags
Rhea-AI Summary
Electromed, Inc. announces record revenue in Q2 FY 2024, with a 17% increase to $13.7 million. Gross margins improved to 77%, while operating income reached $2.26 million. Net income was $1.67 million, with cash at $10.4 million. The company attributes growth to product development and market expansion.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
26.92%
Tags
-
Rhea-AI Summary
Electromed, Inc. announced the release of its financial results for the fiscal 2024 second quarter, with a conference call scheduled to discuss the results. The call will take place on February 13, 2024, at 5:00 p.m. Eastern Time, and interested parties can participate via phone or webcast. A replay of the call will also be available for those who cannot listen to the live broadcast.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.28%
Tags
-
Rhea-AI Summary
Electromed, Inc. (ELMD) has entered into a distribution agreement with Marathon Medical Corp., a service-disabled veteran-owned small business, to distribute its SmartVest® Airway Clearance System for High Frequency Chest Wall Oscillation therapy. This partnership aims to provide easier access to the therapy for government facilities, including VA hospitals and clinics, Indian Health Service hospitals and clinics, and other Federal agencies, ultimately improving the quality of life for US veterans, Federal employees, and Native American peoples.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.18%
Tags
Rhea-AI Summary
Electromed, Inc. (ELMD) announced that its President and CEO, Jim Cunniff, and CFO, Brad Nagel, will attend the 2024 Lytham Partners Investor Select Conference on February 1, 2024. The management team will participate in a fireside chat and investor 1x1s, with the fireside chat scheduled for 11 am Eastern Time. Interested parties can register for the fireside chat using the provided link.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.6%
Tags
-
Rhea-AI Summary
ELMD Electromed Reports 16% Revenue Growth in Q1 FY 2024
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.09%
Tags
-
Rhea-AI Summary
Electromed, Inc. has launched the SmartVest Clearway Airway Clearance System for inpatient use in hospitals. The system uses High Frequency Chest Wall Oscillation therapy to clear excess secretions from the lungs and reduce the risk of respiratory infections. It provides therapeutic relief for patients with ineffective secretion clearance and aims to speed up patient recovery.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.1%
Tags
Rhea-AI Summary
Electromed, Inc. announced that its President and CEO, Jim Cunniff, and CFO, Brad Nagel, will attend the Canaccord Genuity MedTech, Diagnostics, and Digital Health & Services Forum on November 16, 2023 in New York City. The management team will engage in investor 1x1s on the same day.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.66%
Tags
Electromed, Inc.
NYSE:ELMD
ELMD Rankings
ELMD Stock Data
159.20M
5.88M
26.7%
32.78%
0.5%
Surgical and Medical Instrument Manufacturing
Manufacturing
United States of America
NEW PRAGUE
About ELMD
electromed, inc. is a minnesota-based company (nyse mkt: elmd) and the innovative leader in the development, manufacture, and worldwide sales of the smartvest® airway clearance system. the patented system uses high frequency chest wall oscillation (hfcwo), a better-tolerated alternative to chest physiotherapy (cpt), to deliver vigorous, yet comfortable airway clearance treatment for patients battling the consequences of retained secretions. hfcwo has been clinically proven to clear the lungs of excess mucus, improve and reduce lung infections for individuals suffering from various conditions including atelectasis, copd, bronchiectasis, neuromuscular diseases, and cystic fibrosis. electromed, inc. is accredited by the joint commission and is iso 13485:2003 and iso 9001:2008 certified.